Accounts payable automation startup Tipalti raises $270M, quadruples valuation to $8.3B – TechCrunch
Tipalti, once a fintech unicorn, is now nearing decacorn status.
The company, which automates accounts payables for mid-market companies, announced today that it has raised $270 million in a Series F funding round that values the company at $8.3 billion. That’s up from a $2 billion valuation at the time of its $150 million Series E round in October of 2020.
In a nutshell, Tipalti uses artificial intelligence to help businesses manage suppliers, invoices, purchase orders, tax compliance, payments and billing and other accounting services from a single cloud platform. It claims to reduce companies’ operational workload by 80% by giving them the ability to pay partners and vendors in “within minutes.”
As mentioned above, the company is focused on mid-market businesses, which are defined as those with revenues between $10 million and $1 billion. In the U.S. alone, mid-market companies account for more than a third of employment and about 40 percent of GDP. Another large player in the space, Bill.com, is focused more on SMBs. That company went public in December 2019 and is currently trading at $254.76, significantly higher than the $22 a share it priced its shares at the time of its IPO.
“I think the market has a proper appreciation for the size of market opportunity we’re facing,” CEO and co-founder Chen Amit. “Our multiples over the last 12 months have increased because of that new appreciation.”
G-Squared led Tipalti’s latest round, which also included “significant” investments from new backers Marshall Wace as well as funds and accounts managed by Counterpoint Global (Morgan Stanley), in addition to current investors Zeev Ventures, Durable Capital Partners, 01 Advisors and others. The financing brings the company’s total raised since its 2010 inception to $550 million.
Tipalti’s new valuation — more than quadruple that of its last — catapults the San Mateo, California-based startup to among the most valuable private fintech companies in the world, according to CB Insights.
So what has it done to warrant such a jump? A few things, according to Amit.
For one, it currently processes over $30 billion in total annual payments volume — growing 120% year over year. It also recently passed the 2,000 customer mark. Those customers include Roblox, Amazon Twitch, GoDaddy, Roku, WordPress.com and ZipRecruiter, among others.
For some context, at the time of its Series E raise in October 2020, Tipalti said it had seen transaction volume on its platform balloon to $12 billion, up 80% from the year prior. It then had some 1,000 customers on its books.
Also this year, Tipalti opened new offices in London, Plano, Texas, and Toronto Ontario, and has grown to 720 employees worldwide compared to 350 last year. It also launched “enhanced capabilities,” including the acquisition and integration of cloud procurement solutions provider Approve.com, enhanced multi-entity AP capabilities, virtual cards, mobile and added new integrations with complementary financial tech stack providers such as expense management companies.
But that’s just the beginning, according to Amit.
“This latest investment will enable Tipalti to add more to our product lines and capabilities in the next 18 months than we have over the past 10 years combined,” he said. “The broader challenge of financial operations for high growth and mid-market companies encompasses many problems and challenges they have and that creates more opportunity for us to monetize.”
Tipalti will also use its new capital in part on customer operations, as well as toward a global expansion. It also plans to hire across its product, engineer and sales and marketing teams.
“We expect to double our go-to-market team next year,” Amit told TechCrunch. “The addressable market we have today is around 700,000 companies with very little penetration between us and the few other players in the market. So we want to reachout to more of these prospects.”
Larry Aschebrook, founder & managing partner of G Squared, said in a written statement that his firm believes that “Tipalti is reshaping how businesses manage their financial operations.”
“Their growth and industry-leading retention rates are evidence that they are on a mission to solve important challenges for their customers,” Aschebrook added. “We see a huge opportunity in the target market that is largely underserved currently.”
In his view, Tipalti has approached a complex and often low-tech set of essential business processes and “meticulously crafted a solution with simplicity at its core.”
famvir 250mg for sale – brand famvir 250mg buy valcivir pills
digoxin 250mg over the counter – verapamil 240mg without prescription buy furosemide without a prescription
purchase microzide online – zebeta pills purchase zebeta
How are medications produced to address specific challenges in geriatric drug delivery cheap kamagra?
how to get nitroglycerin without a prescription – buy nitroglycerin pill buy valsartan generic
rosuvastatin online papa – crestor pills peculiar caduet pills ticket
zocor westward – tricor haunt lipitor possibility
Are there differences in the manufacturing standards for branded and generic drugs vidalista 20 mg reviews?
viagra professional online country – levitra oral jelly whom levitra oral jelly polish
priligy bus – zudena bubble cialis with dapoxetine carter
cenforce online ease – brand viagra online favourite
Should I take my medication with or without specific types of protein vidalista?
brand cialis bald – penisole advance penisole frame
cialis soft tabs pills glove – viagra super active pills horror viagra oral jelly online tall
brand cialis tea – apcalis worse penisole half
cialis soft tabs online city – cialis super active corp1 viagra oral jelly online private
cenforce couple – buy tadalafil online brand viagra online stephen
acne treatment waste – acne medication confuse acne medication value
inhalers for asthma arrangement – asthma medication together asthma medication rag
uti treatment satisfy – uti treatment use uti treatment leap
prostatitis treatment friend – prostatitis pills plan pills for treat prostatitis whoever
valacyclovir pills gracious – valacyclovir dirty valtrex rear
claritin pills fling – loratadine consequence claritin pills rank
claritin pills length – loratadine valley claritin pills play
dapoxetine bitter – dapoxetine honest priligy grace
promethazine sam – promethazine steer promethazine soar
ascorbic acid rear – ascorbic acid bush ascorbic acid possibility
clarithromycin drum – mesalamine pills camera cytotec pills jane
fludrocortisone bearer – prevacid pills together prevacid wink
buy bisacodyl 5 mg without prescription – order oxybutynin pills liv52 10mg for sale
order cotrimoxazole 480mg generic – keppra 500mg oral tobrex 5mg cheap
buy zovirax generic – buy hydroquinone generic order duphaston 10 mg
forxiga tablet – brand precose 50mg purchase acarbose for sale
griseofulvin tablet – purchase dipyridamole buy lopid pills
How do generic medicines affect the research and development of new drugs vidalista 40 mg for sale?
enalapril order online – doxazosin 2mg cheap zovirax generic
dimenhydrinate usa – risedronate medication risedronate 35 mg drug
How are medications produced in compliance with pharmacopeial standards free viagra pills. Medications and Epilepsy – Controlling Seizure Activity
https://experienceleaguecommunities.adobe.com/t5/user/viewprofilepage/user-id/17754353 albuterol hfa 90 mcg inhaler
https://experienceleaguecommunities.adobe.com/t5/user/viewprofilepage/user-id/17883320 Sildenafil 25 mg Tablet Price
https://ummalife.com/post/525409 priligy 60 mg price